Koers Pure Global Cannabis Inc Toronto S.E.
Aandelen
RSL
CA7806782073
Farmaceutische producten
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 24,16 mln. 32,94 mln. 22,25 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | - 0 0 | Nettowinst (verlies) 2018 | -23 mln. -31,36 mln. -21,18 mln. | EV/omzet 2017 * | - |
Nettoschuld 2017 | 211K 288K 194K | Nettoschuld 2018 | 4,49 mln. 6,12 mln. 4,14 mln. | EV/omzet 2018 | - |
K/w-verhouding 2017 * |
-
| K/w-verhouding 2018 |
-0,72
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 83,64% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vik Chopra
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjeev Goel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Lavergne
PRN | Corporate Officer/Principal | - | 30-07-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jane E. Pagel
BRD | Director/Board Member | - | 01-07-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,31% | 6,19 mld. | |
-16,99% | 4,48 mld. | |
+6,39% | 3,29 mld. | |
-13,10% | 3,12 mld. | |
-4,17% | 2,5 mld. | |
+45,47% | 1,94 mld. | |
-9,11% | 1,68 mld. | |
-2,09% | 1,64 mld. | |
-12,50% | 1,56 mld. |